Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | OATD-02 |
Synonyms | |
Therapy Description |
OATD-02 inhibits ARG1 and ARG2, which potentially increases antitumor immune response and decreases tumor growth (PMID: 36939275, PMID: 36010962). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
OATD-02 | OATD 02|OATD02|OAT1746|OAT 1746|OAT-1746 | OATD-02 inhibits ARG1 and ARG2, which potentially increases antitumor immune response and decreases tumor growth (PMID: 36939275, PMID: 36010962). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT05759923 | Phase I | OATD-02 | First-in-human Phase I Study to Evaluate Safety, Tolerability and Antineoplastic Activity of OATD-02 in Patients With Selected Advanced and/or Metastatic Solid Tumours | Recruiting | POL | 0 |